The Trials and Tribulations of Pentoxifylline

Abstract

Get full access to this article

View all access options for this article.

References

Reid DD , Brett GZ , Hamilton PJ , et al. Cardiorespiratory disease and diabetes among middle-aged male civil servants: A study of screening and intervention. Lancet 1:469-473, 1974.

Schroll M. , Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis 34:261-269, 1981.

Criqui MH , Fronek A. , Barrett-Conner E. , et al. The prevalence of peripheral arterial disease in a defined population . Circulation 71:510-515, 1985.

Kannell WB , McGree DL Update on some epidemiological features of intermittent claudication: The Framingham study. J Am Geriatr Soc 33:13-18, 1985.

Boyd AM Natural course of arteriosclerosis of lower extremities. Proc R Soc Med 53:591, 1962.

Imparato AM , Kim GE , Davidson T. , et al. Intermittent claudication: Its natural course. Surgery 78:795-799, 1975.

Boobis IH , Bell PRF.

Can drugs help patients with lower limb ischaemia?

Br J Surg 69(Suppl):17-23, 1982.

Jelnes R. , Gaardsteing O. , Hougaard Jensen K , et al. Fate in intermittent claudication: Outcome and risk factors . Br Med J 293:1137-1140, 1978 .

Lassila R. , Lepantalo M. , Lindfors O. Peripheral arterial disease—Natural outcome. Acta Med Scand 220:295-301, 1986.

10.

Kannel WB , Skinner JJ Jr , Schwartz MG , et al. Intermittent claudication. Incidence in the Framingham study Circulation 41:875-883, 1970.

11.

Coffman JD Intermittent claudication: Not so benign. Am Heart J 112:1127-1128, 1986.

12.

Kennel WB , McGee DL Update on some epidemiologic features of intermittent claudication: The Framingham study. J Am Geriatr Soc 33:13-18, 1985.

13.

Krupski WC , Effeney DJ Arteries. In Way LW , ed. Current Surgical Diagnosis and Treatment. San Mateo, Calif.: Appleton & Lange, 1991.

14.

Ruckley CV Claudication. Br Med J 292:970-971, 1986.

15.

Hubner C. Exercise therapy and smoking cessation for intermittent claudication . J Cardiovasc Nurs 1:50-58, 1987.

16.

Verstraete M. Current therapy for intermittent claudication . Drugs 24:240-247, 1982.

17.

Coffman JD New drug therapy in peripheral vascular disease. Med Clin North Am 72: 259-265, 1988.

18.

Do drugs help intermittent claudication?

Drug Ther Bull 28:1-2, 1990.

19.

Bevan EG , Waller PC , Ramsay LE Pharmacological approaches to the treatment of intermittent claudication . Drugs Aging 2:125-136, 1992.

20.

Meynaud A. , Grand M. , Fontaine L. Effet du naftidrofuryl sur le metabolism energetique cerebral. Arzneimittelforschung 23:1431-1436, 1973 .

21.

Shaw SWJ , Johnson RH The effect of naftidrofuryl in the metabolic response to exercise in man. Acta Neurol Scand 52:231-237, 1975.

22.

Naftidrofuryl (Praxilene). Drug Ther Bull 26:25-27, 1988.

23.

Ruckley CV , Callam MJ , Ferrington CM , et al. Naftidrofuryl for intermittent claudication: A double-blind controlled trial. Br Med J 1:622, 1978.

24.

Clyne CAC , Galland RB , Fox MJ , et al. A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication. Br J Surg 67:347-348, 1980.

25.

Adhoute G. , Bacourt F. , Barral M. , et al. Naftidrofuryl in chronic arterial disease: Results of a six month controlled multicenter study using naftidrofuryl tablets 200 mg. Angiology 37: 160-167, 1986.

26.

Trubestein G. , Bohme H. , Heidrich H. , et al. Naftidrofuryl in chronic arterial disease: Results of a controlled multicenter study. Angiology 35:701-708, 1984.

27.

Kamik R. , Valentin A. , Stollberger C. , et al. Effects of naftidrofuryl in patients with intermittent claudication . Angiology 39:234-240, 1988.

28.

Acetto B. Beneficial hemorrheologic therapy of chronic peripheral arterial disorders with pentoxifylline: Results of double-blind study versus vasodilator-nylidrin . Am Heart J 103: 864-869, 1982.

29.

Porter JM , Rivers SP , Anderson CJ , et al. Evaluation and management of patients with Raynauds syndrome . Am J Surg 142:183-188, 1981.

30.

Angelkort B. , Doppelfield E. Treatment of chronic arterial occlusive disease. Clinical study with a new gagenic preparation of pentoxifylline. Pharmatherapeutica 3(Suppl 1):18, 1983.

31.

Grigoleit HG , Porsche E. , Stefanovich V. , et al. The effect of pentoxifylline on red cell flexibility in healthy subjects after administration of Trental 400. Pharmatherapeutica 1(4): 241-247, 1976.

32.

Taylor LM , Porter JM Circulation enhancing drugs. In Rutherford RB , ed. Vascular Surgery. Philadelphia : WB Saunders, 1989.

33.

Matsky R. , Darius R. , Schor K. The release of prostacyclin by pentoxifylline from human vascular tissue. Arzneimettelforschung 32:1315-1318, 1982 .

34.

Weithman KU Reduced platelet aggregation by pentoxifylline stimulated prostacyclin release. Vasa 10:249-252, 1981.

35.

Manrique RV , Manrique V. Platelet resistance to prostacyclin enhancement of the antiaggretory effect by pentoxifylline. Angiology 38:101-108, 1987.

36.

Aviado DM , Dettelbach HR Pharmacology of pentoxifylline a hemorrheologic agent for the treatment of intermittent claudication. Angiology 35:407-417, 1984.

37.

Sowemimo-Coker SO , Turner P. The effect of pentoxifylline on filterability of normal red cells and their adhesiveness to cultured endothelial cells. Eur J Clin Pharmacol 29:55-59, 1985.

38.

Stefanovich V. Effect of pentoxifylline on energy rich phosphates in rats erythrocytes. Res Commun Chem Pathol Parmacol 10:747-750, 1975.

39.

Matrai A. , Ernst E. Pentoxifylline impairs white cell rheology in claudicants. Clin Haemorrheol 5:483-487, 1986.

40.

Schmid-Schonbehn GW , Usami S. , Skalak R. , et al. The interaction of leucocytes and erythrocytes in capillary and post capillary vessels. Microvasc Res 19:47-50, 1980.

41.

Currie MS , Simel DL , Christenson RH , et al. Anti inflammatory effects of pentoxifylline in claudication . Am J Med Sci 301:85-90, 1991.

42.

Spitell JA

Pentoxifylline and vascular disease. Rational

Drug Ther 20:4-6, 1986.

43.

Porter JM , Cutler BC , Lee BY , et al. Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 104:66-72, 1982.

44.

Green RM , McNamara J. The effects of pentoxifylline on patients with intermittent claudication . J Vasc Surg 7:356-362, 1988.

45.

Cameron HA , Waller PC , Ramsay LE Drug treatment of intermittent claudication: A critical analysis of the methods and findings of published clinical trials 1965-1985. Br J Pharmacol 26:569-576, 1988.

46.

Hills M. , Armitage P. The two-period crossover clinical trial. Br J Pharmacol 8:7-20, 1979.

47.

Zikmund WG Business Research Methods, 3rd ed. Chicago: The Dryden Press, 1984.

48.

Waller PC , Solomon SA , Ramsay LE The acute effects of cigarette smoking on treadmill exercise distances in patients with stable intermittent claudication. Angiology 40:164-169, 1989.

49.

Bollinger A. , Frei C. Double-blind study of pentoxifylline against placebo in patients with intermittent claudication. Pharmatherapeutica 1:557-562, 1977.

50.

Chopra HK , Chopra KL , Aggarwal KK , et al. Pentoxifylline: A new drug for the treatment of peripheral chronic occlusive arterial disease. J Med 19:89-107, 1988.

51.

Dettori AG , Pini M. , Moratti A. , et al. Acenocoumarol and pentoxifylline in intermittent claudication . A controlled clinical study. The APIC Study Group. Angiology 40:237-248, 1989.

52.

Di Perri T. , Guerrini M. Placebo controlled double-blind study with pentoxifylline of walking performance in patients with intermittent claudication. Angiology 34:40-45, 1983.

53.

Donaldson DR , Hall TJ , Kester RC , et al. Does oxpentifylline have a place in the treatment of intermittent claudication. Curr Med Res Opin 9:35-40, 1984.

54.

Ernst E. , Kollar L. , Resch KL Does pentoxifylline prolong the walking distance in exercised claudicants. A placebo controlled double-blind trial. Angiology 43:121-125, 1992.

55.

Gallus AS , Morley AA , Gleadow F. , et al. Intermittent claudication: A double-blind crossover trial of pentoxifylline. Aust N Z J Med 15:402-409, 1985.

56.

Lingarde F. , Jelnes R. , Bjorkman H. , et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation 80:1549-1556, 1989.

57.

Perhoniemi V. , Salmenkivi K. , Sunberg S. , et al. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication . Angiology 35:366-372, 1984.

58.

Reich T. , Cutler BC , Lee BY , et al. Pentoxifylline in the treatment of intermittent claudication of the lower limbs. Angiology 35:389-395, 1984.

59.

Reich T. , Gillings D. Effects of pentoxifylline on severe intermittent claudication. Angiology 38:651-656, 1987.

60.

Reilly DT , Quinton DN , Barrie WW A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: Clinical, haemostatic and rheological effects. N Z Med J 100: 445-447, 1987.

61.

Roekaerts F. , Deleers L. Trental 400 in the treatment of intermittent claudication: Results of long-term, placebo-controlled administration . Angiology 35:396-406, 1984.

62.

Strano A. , Davi G. , Avellone G. , et al. Double-blind, crossover study of the clinical efficacy and the hemorrheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 35:459-466, 1984.

63.

Radack K. , Wyderski RJ Conservative management of intermittent claudication. Ann Intern Med 113:135-146, 1990.

64.

Stergachis A. , Sheingold S. , Luce B. , et al. Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease . Arch Intern Med 152:1220-1224, 1992 .